SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,354 | -99.6% | 755 | -99.8% | 0.00% | -100.0% |
| Q1 2020 | $6,237,000 | +110.3% | 346,666 | +488.6% | 0.05% | +325.0% |
| Q3 2018 | $2,966,000 | -85.8% | 58,900 | -83.2% | 0.01% | -85.7% |
| Q2 2018 | $20,948,000 | +43541.7% | 350,000 | +18321.1% | 0.08% | – |
| Q4 2016 | $48,000 | -93.4% | 1,900 | -94.7% | 0.00% | -100.0% |
| Q2 2016 | $725,000 | -95.0% | 35,600 | -96.2% | 0.01% | -95.5% |
| Q1 2016 | $14,407,000 | – | 944,746 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |